. Therefore, this list reflects the evaluation of small molecule drugs under research by industry experts. The voting results showed that Gilead Sciences
66% increase in effectiveness! The latest results of a long-acting HIV prevention drug are released once every two months.
Time of Update: 2020-10-21
ViiV Healthcare announced on July 7th that injections of the long-acting drug cabottegravir (CAB) every two months were better than daily oral encourtabin/tenofovir fumarate tablets (FTC/TDF, 200mg/300mg, Truvada), based on data analyzed by the HIV
The release of the first long-term survival data for head and neck squamous cancer has brought new hope to patients.
Time of Update: 2020-10-14
to the positive results of long-term follow-up to lung cancer and melanoma, head and neck squamous cancer also released four-year survival data, continuing to break through to five-year survival. believe that in the near future, there will be a large number
Nearly 20,000 patients participated! Novartis releases long-term positive data for Aimovig's real world.
Time of Update: 2020-08-01
On April 16, Novartis released the latest clinical data on Aimovig's preventive migraine treatment, confirming the true and long-term safety and efficacy of the drug for patients with occasional and chronic migraines.
Alnylam's release of long-term data on Givlaari's treatment of AHP is expected to dispel safety questions.
Time of Update: 2020-07-31
and the huge advantage of only 2 subcutaneous injections per year, the drug has a very good market penetration opportunity. Source: 1, Alnylam's RNAi the Girapy ari show lasting effect one life into treatment, new data show 2, Alnylam Reports New 12-Interim Interim Data From the Phase 3 Gevosiran in Siomh Porphyria.
Long prescription policy release, a batch of drugs or usher in incremental expectations
Time of Update: 2020-07-15
Pharmaceutical Network Market Analysis ) Long-term prescription is suitable for patients with chronic diseases with clear clinical diagnosis, stable drug regimen, good compliance, stable disease control, and long-term drug treatment
FDA approves Alexion's long-acting C5 tonic inhibitor Ultromiris (ravulizumab-cwvz) extended indications
Time of Update: 2020-06-07
FDA ( approved the company's long-acting C5 tonic inhibitor Ultromiris (ravulizumab-cwvz) extended indications for the treatment of atypical hemolytic uremic syndrome (aHUS) patients (aHUS) patients (more than one month old) to complement the tonic-mediated thrombosis (TAM).
A prescription has long been available, multi-site pharmacies are released
Time of Update: 2020-06-01
For many times to buy drugs of patients with slow disease, still need to ask for a prescription every time, patients do not understand, pharmacies difficult, such difficult to buy medicine and sell drugs difficult to be embarrassed, but also
Approved extended indications of Sanofi long-acting insulin for the benefit of patients with type 1 diabetes
Time of Update: 2019-11-28
Recently, the U.S. FDA approved the extension of toujeo, a long-acting insulin glargine injection from Sanofi, for the treatment of children and adolescents with type 1 diabetes mellitus aged 6 and above.
R & D daily / Sanofi long acting insulin approved for extended indications
Time of Update: 2019-11-28
Innovative therapy targeting FGF receptor Incyte cholangiocarcinoma has been qualified for priority review; Sanofi long-acting insulin has been approved to expand the indications for the benefit of type 1 diabetic patients; anticoagulation therapy for children!
The Third International Forum on long-term and sustained-release new drug research and development came to a successful end
Time of Update: 2019-11-19
On November 16, the third international long-term sustained release new drug research and Development Summit Forum and 2019 Hunan Pharmaceutical raw and auxiliary materials
The Third International Forum on long-term and sustained release new drug research and development opened in Changsha
Time of Update: 2019-11-19
On November 15, the third international long-term sustained release new drug R & D Summit Forum and 2019 Hunan Pharmaceutical raw and auxiliary materials Industrial Park (Changsha
Immunotherapy for metastatic Merkel cell carcinoma! Merck / Pfizer released bavencio's three-year data, with long-lasting efficacy and good safety!
Time of Update: 2019-10-23
October 23, 2019 / BIOON / -- Merck KGaA and Pfizer, partners, recently published the three-year results of the key phase II javelin Merkel 200 trial Part A, which involved
How to extend the service life of automatic labeling machine for a long time?
Time of Update: 2019-08-20
[technical article of pharmaceutical network] the labeling machine industry in China has experienced several stages of development
From the introduction and imitation
Release of "you Nong and I Nong special feeling" in VIP Quarterly "long feeling" list of pharmaceutical intelligence data
Time of Update: 2018-11-07
For this reason, we hereby issue "you Nong me Nong special sentiment list" based on the number of times VIP users use the drug intelligence data.
Release of "infatuation list" in VIP Quarterly "long love" list of pharmaceutical intelligence data
Time of Update: 2018-11-06
Therefore, according to the recent frequency of using the database by VIP users, we hereby issue the "infatuation list".